Simvastatin 40 mg, rosuvastatin 10 mg and simvastatin/ezetimibe 10/10 mg are associated with similar adverse effects on insulin resistance.
The authors state no conflict of interest and have received no payment in preparation of this manuscript. Some of the authors (EL, DM, HM and EM) have given talks, attended conferences and participated in trials and advisory boards sponsored by various pharmaceutical companies.
Int J Clin Pract. 2011;65(11):1141-1148. © 2011 Blackwell Publishing
Cite this: Comparison of the Effects of Simvastatin vs. Rosuvastatin vs. Simvastatin/Ezetimibe on Parameters of Insulin Resistance - Medscape - Nov 01, 2011.